Yongan Pharmaceutical: The price of taurine stopped falling in May and began to rebound, but the price increase is a gradual process.

Yong'an Pharmaceutical stated on the interactive platform on July 16 that after a 3-year adjustment, the price of taurine stopped falling in May this year and began to rebound. However, the price increase is a gradual process. According to the company's 2025 interim performance forecast, the company's performance in the first half of the year significantly decreased compared to the same period last year, mainly due to the impact of a sluggish market situation. The main reason is that the sales volume and selling price of the company's main product, taurine, have both decreased compared to the same period last year.